The epidemiology and spread of drug resistant human influenza viruses
作者： Aeron C Hurt
DOI: 10.1016/J.COVIRO.2014.04.009
关键词:
摘要: … Due to the high mutation rate of influenza viruses during replication, there are ever-present opportunities for … , the same mutation was beginning to be detected in former seasonal A(…
elsevier.com
sci-hub.se 
researchgate.net 参考文章(67)
R Pebody, A Lackenby, C Moore, J Ellis, M Galiano, M Zambon, J McMenamin, P Muir, A Bermingham, M Guiver, S Miah, CI Thompson, I Vipond, A Reynolds, J Moran Gilad, S Bolotin, R Gunson, L Calatayud, Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Eurosurveillance. ,vol. 16, pp. 19784- ,(2011) , 10.2807/ESE.16.05.19784-EN
Update on avian influenza A (H5N1) virus infection in humans. The New England Journal of Medicine. ,vol. 358, pp. 261- 273 ,(2008) , 10.1056/NEJMRA0707279
Margo Schilling, Stefan Gravenstein, Paul Drinka, Nancy Cox, Peggy Krause, Laura Povinelli, Peter Shult, Emergence and Transmission of Amantadine‐Resistant Influenza A in a Nursing Home Journal of the American Geriatrics Society. ,vol. 52, pp. 2069- 2073 ,(2004) , 10.1111/J.1532-5415.2004.52567.X
Frederick G. Hayden, Newer influenza antivirals, biotherapeutics and combinations. Influenza and Other Respiratory Viruses. ,vol. 7, pp. 63- 75 ,(2013) , 10.1111/IRV.12045
R B Belshe, M H Smith, C B Hall, R Betts, A J Hay, Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. Journal of Virology. ,vol. 62, pp. 1508- 1512 ,(1988) , 10.1128/JVI.62.5.1508-1512.1988
Hideyuki Ikematsu, Naoki Kawai, Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza. Expert Review of Anti-infective Therapy. ,vol. 9, pp. 851- 857 ,(2011) , 10.1586/ERI.11.112
J.A.L. Ives, J.A. Carr, D.B. Mendel, C.Y. Tai, R. Lambkin, L. Kelly, J.S. Oxford, F.G. Hayden, N.A. Roberts, The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. Antiviral Research. ,vol. 55, pp. 307- 317 ,(2002) , 10.1016/S0166-3542(02)00053-0
P.M. Colman, Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Science. ,vol. 3, pp. 1687- 1696 ,(1994) , 10.1002/PRO.5560031007
E. C. Holmes, Helping the Resistance Science. ,vol. 328, pp. 1243- 1244 ,(2010) , 10.1126/SCIENCE.1190994
A.C. Hurt, P. Selleck, N. Komadina, R. Shaw, L. Brown, I.G. Barr, Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Research. ,vol. 73, pp. 228- 231 ,(2007) , 10.1016/J.ANTIVIRAL.2006.10.004